![Gerald Krystal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerald Krystal
Plus aucun poste en cours
Profil
Gerald Krystal was associated with Aquinox Pharmaceuticals, Inc. as the founder and held the position of Chief Scientific Officer from 2010 to 2013.
Aquinox Pharmaceuticals, Inc. was founded in 2003.
Anciens postes connus de Gerald Krystal
Sociétés | Poste | Fin |
---|---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |